+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment



Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment



Acta Neurologica Belgica 107(1): 14-17



The authors report the case of a 54-year old type-2 diabetic female patient with a Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). She progressively developed distal hypoesthesia and tetraparesis. She deteriorated after two courses of intravenous immunoglobulins (IVIG) administration and became rapidly wheelchair bound. After one month of steroid treatment, the patient was walking alone. This case raises the question whether IVIG is to be considered as first line treatment for diabetes associated CIDP.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052080055

Download citation: RISBibTeXText

PMID: 17569228


Related references

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins. Biologics 4: 45-49, 2010

Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins. Journal of Neuroinflammation 12: 148, 2016

Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients. Clinical and Experimental Immunology 178 Suppl 1: 149-150, 2015

Response to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy with only sensory symptoms. Journal of Neurology 243(4): 318-322, 1996

Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System 11(4): 325-329, 2006

Treatment Response to Steroid and Intravenous Immunoglobulin in a Patient with Chronic Sensory Demyelinating Neuropathy. Journal of Clinical Neuromuscular Disease 8(4): 207-211, 2007

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Annals of Neurology 30(1): 104-106, 1991

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology 51(6 Suppl 5): S16-S21, 1998

An "n of 1" trial of intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy. Journal of Neurology, Neurosurgery, and Psychiatry 57(9): 1137, 1994

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Journal of Neurology, Neurosurgery & Psychiatry 57(Suppl): 38-42, 1994

Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins. Neurosciences 5(1): 69-71, 2000

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. No to Shinkei 44(11): 979-982, 1992

The treatment of hiv associated chronic inflammatory demyelinating polyneuropathy hiv cidp with intravenous immunoglobulin ivig. Neurology 42(4 SUPPL 3): 335, 1992

Treatment of chronic inflammatory demyelinating polyneuropathy cidp with intravenous immunoglobulin ivig. Journal of Allergy & Clinical Immunology 85(1 PART 2): 222, 1990

Pure sensory chronic inflammatory polyneuropathy: rapid deterioration after steroid treatment. Bmc Neurology 15: 27, 2016